Back

Multi-level Analysis of Codon Usage Patterns Reveals Systematic Optimization of Oncogenic Gene Expression in Pancreatic Cancer

Mueller, L.; Glass, M.; Preckwinkel, P.; Huettelmaier, S.; Haemmerle, M.; Gutschner, T.

2026-04-28 cancer biology
10.64898/2026.04.24.720399 bioRxiv
Show abstract

BackgroundCodon usage bias, the non-random usage of synonymous codons in coding sequences, represents a fundamental feature of genomic organization that has been largely understudied in cancer biology. Pancreatic ductal adenocarcinoma (PDAC), the predominant subtype of pancreatic cancer, is characterized by aggressive disease progression and limited therapeutic options, necessitating novel approaches to understand its molecular pathogenesis. Leveraging publicly available single-cell RNA sequencing data, we performed comprehensive codon usage analyses across different cellular populations in PDAC. ResultsEmploying a variety of computational codon usage indices uncovered the connections between cancer-specific cellular state features and codon usage signatures. Our findings reveal that malignant pancreatic cells express genes with significantly higher GC content, demonstrate preferential usage of optimal codons through increased frequency of preferred synonymous codons, and exhibit a marked preference for more cost-effective amino acids. Analysis of transcript-level bulk RNA-seq data from PDAC tumors revealed that these codon optimization patterns extend to alternative isoform usage, with highly expressed isoforms displaying increased codon optimality and enhanced mRNA stability. ConclusionThese codon usage-dependent adaptations operating at both gene expression and transcript isoform levels may enable malignant cells to enhance gene expression rates, potentially leading to increased translational efficiency and protein production. These insights into the codon usage landscape of PDAC may provide potential biomarkers for disease monitoring and treatment response prediction.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
BMC Cancer
52 papers in training set
Top 0.1%
22.5%
2
Scientific Reports
3102 papers in training set
Top 5%
10.4%
3
PeerJ
261 papers in training set
Top 0.4%
6.8%
4
Cancers
200 papers in training set
Top 0.9%
6.3%
5
PLOS Computational Biology
1633 papers in training set
Top 7%
4.8%
50% of probability mass above
6
PLOS ONE
4510 papers in training set
Top 39%
3.6%
7
International Journal of Cancer
42 papers in training set
Top 0.4%
2.6%
8
npj Genomic Medicine
33 papers in training set
Top 0.2%
2.4%
9
Computers in Biology and Medicine
120 papers in training set
Top 2%
1.9%
10
Cancer Medicine
24 papers in training set
Top 0.7%
1.8%
11
Cancer Research Communications
46 papers in training set
Top 0.5%
1.7%
12
Computational and Structural Biotechnology Journal
216 papers in training set
Top 5%
1.5%
13
npj Systems Biology and Applications
99 papers in training set
Top 1%
1.3%
14
Journal of Translational Medicine
46 papers in training set
Top 1%
1.3%
15
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
16
International Journal of Molecular Sciences
453 papers in training set
Top 11%
1.1%
17
Journal of Proteome Research
215 papers in training set
Top 2%
0.9%
18
Translational Oncology
18 papers in training set
Top 0.3%
0.9%
19
Cancer Letters
32 papers in training set
Top 0.6%
0.9%
20
Communications Biology
886 papers in training set
Top 19%
0.9%
21
Cancer Research
116 papers in training set
Top 3%
0.8%
22
Cell Death & Disease
126 papers in training set
Top 3%
0.7%
23
Molecular Cancer
14 papers in training set
Top 1.0%
0.7%
24
Gastroenterology
40 papers in training set
Top 2%
0.7%
25
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.7%
0.7%
26
F1000Research
79 papers in training set
Top 6%
0.6%
27
Frontiers in Genetics
197 papers in training set
Top 11%
0.6%
28
Genome Medicine
154 papers in training set
Top 9%
0.6%
29
eBioMedicine
130 papers in training set
Top 5%
0.6%
30
eLife
5422 papers in training set
Top 62%
0.6%